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Abstract
Purpose The aim of our study was to find whether an injury
of the knee joint tissues increases gene expression of selected
hyaline cartilage degenerating enzymes such as matrix
metaloproteinases (MMP) and aggreacaneses (Agg).
Methods A total of 138 patients (81 female, 57 male) were
admitted for knee arthroscopy with a mean age of 38.8 years.
Full blood samples were collected preoperatively and
synovium samples intraoperatively. Joint tissue lesions such
as menisci, anterior cruciate ligament (ACL) and hyaline
cartilage were estimated. Real time PCR with spectrophoto-
metric analysis was performed.
Results An ACL lesion was found in 56 patients, medial
menisci (MM) in 65, and lateral menisci (LM) in five.
Chondral lesions were estimated according to Outerbridge’s
grading system. In laboratory tests correlation between ACL
tear and gene expression was seen except TIMP1 in serum (p
<0.05). In MM lesions MMP9, Agg2 elevation in serum was
observed. LM lesions erased MMP13, MMP14 in serum and
MMP8 in synovium. Chondral lesions revealed that many
genes had higher expression in patients without hyaline
degeneration. All of the gene expressions correlated between
serum and synovium.
Conclusion An ACL lesion provokes elevation in expression
of proteases genes, while the influence of other lesions re-
mains elusive. Gene expression in synovium correlates with
peripheral blood.
Keywords Osteoarthritis . Hyaline cartilage .
Metaloproteinases . Agrecanases . ACL .Menisci
Introduction
It is estimated that, during the year 1995, 40 million people
were treated for osteoarthritis (OA) in the United States of
America, with a simultaneous prognosis of the annual inci-
dence of the disease to rise up to 59.4 patients in 2020 [1]. The
risk factors for OA include, among others, practising sports
and injuries of a given joint [2]. Gelber et al. demonstrated
that, among subjects with a history of knee joint trauma, as
many as 13.9 % of them presented with OA before the 65th
year of life, while it was only 6 % in the control group [3].
Similarly, in the Framingham study, a five-fold higher risk of
developing OA was estimated in subjects after knee joint
trauma in history [4].
Osteoarthritis is associated with some prevalence of cata-
bolic processes of the hyaline cartilage vs. its regenerative
processes [5, 6]. These changes are controlled by inflamma-
tory cytokines from the synovial membrane and chondrocytes,
such as, for example, IL1 and TNF-α. They are present in
synovial fluid and stimulate the secretion of other cytokines in
addition to influencing the synthesis of articular cartilage
damaging proteases [7–10]. Among the above-mentioned en-
zymes, the key role in articular cartilage destruction is played
by adamlysins (including aggrecanases [Agg]) and matrix
metalloproteinases (MMPs)[9, 10].
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Tajima et al. [11] found that a post-traumatic haematoma
could result from increased MMP2 and MMP9 levels, while
Tchetvierikov observed increased proMMP1 levels in patients
after joint trauma [12]. Some reports are also suggestive of
MMP participation in the reconstruction process of the ante-
rior cruciate ligament (ACL) [13]. It has been documented that
MMP2 levels increase after ACL lesion [14]. Enhanced ac-
tivity of MMP3 of aggrecanase 1 (Agg1) and 2 (Agg2) was
also observed in degeneratively changed menisci [15, 16].
The goal of our study was to find out whether an injury of
knee joint elements increases gene expression in selected
proteases, cytokines and inhibiting factors (MMP1, MMP2,
MMP8, MMP9, MMP13, MMP14, AGG1 and AGG2 prote-
ases, TIMP1 and TIMP2—their inhibitors—and IL1 and
TNFα cytokines). Moreover, we determined whether gene
expression variations in the synovial membrane correlate with
changes in peripheral blood cells.
Material and methods
The study group consisted of 138 patients (81 female, 57
male) admitted for knee joint arthroscopy. In 29 of them,
anterior cruciate ligament reconstruction was simultaneously
performed. In 74 patients, the surgery was carried out in the
right lower limb and in 64, it was the left knee joint. All the
patients who qualified for the study were free of metabolic
diseases, endocrine disorders, rheumatic and connective tissue
diseases, hormonal contraception, steroid therapy, previous
operations or fractures, with no history of nicotine, alcohol
or drug addiction. The mean age in the study group was
38.8 years (median age, 35 years).
Following the qualification procedure into the study group,
peripheral blood samples were collected from each patient on
admission to the hospital. The blood was collected into 2.6-ml
Monovette® EDTA KE test tubes. After 20 minutes at room
temperature, the tubes with collected blood were frozen to a
temperature of −20° C. The peripheral blood was collected
from superficial vessels in the cubital fossa.
The anterolateral or anteromedial arthroscopic ap-
proach was selected in all patients. The knee joint was
evaluated, using a four millimetre arthroscopic camera to
assess the type and degree of possible lesions of the
cruciate ligaments, menisci and the articular cartilage.
Joint surface lesions were classified according to the
Outerbridge scale [17]. Then, fragments of the ACL-
surrounding synovial membrane were collected, either
from approximately half of its length or directly from
the region of its lesion. The collected material samples
were immediately placed in sterile and capped 1.5-cm3
tubes with RNAlater® solution. Such processed samples
were then cooled down to 4 °C and, on the second day,
frozen to −20 °C.
The total cellular RNA was isolated from the synovial
membrane and suspended in RNAlater® solution by the mod-
ified Chomczynski’s method using Trizol® (Invitrogen) re-
agent [18]. A similar procedure was applied to the peripheral
blood samples from EDTA-containing tubes. The isolated
RNA concentration was spectrophotometrically assayed,
measuring absorbance at wave length of 260 nm. Purity of
the isolates was evaluated by means of the A260/A280 coef-
ficient, while RNA concentration and purity were measured
with a Picodrop™ spectrophotometer. The obtained RNA
solution was frozen at −80 °C and stored until further analysis.
The real-time reverse transcription-polymerase chain reac-
tion (RT-PCR) method was applied to assess expression of the
studied genes at the RNA level. The first stage in that method
was a reverse transcription process in which complementary
DNA (cDNA) was obtained and synthesised on mRNA array,
with mRNA having been isolated from blood and tissues. The
isolated RNAwas then subjected to reverse transcription with
an AccuScript High-Fidelity RT-PCR Kit (Agilent Technolo-
gies®). Real-time PCR is the second stage of the RT-PCR
method.
A real-time PCR set, used in our study, encompassed
FastStart Universal Probe Master (ROX) mixture, containing
Taq DNAFastStart polymerase and a set of probes specific for
amplified DNA fragment.
An RT-PCR analysis was carried out with a Stratagene
Mx3005P instrument (Agilent Technologies). The relative
mRNA expression was depicted with the 2-ΔΔCt formula
[19]. The GAPDH gene was used for internal control.
The expression of genes was evaluated in MMP1, MMP2,
MMP8, MMP9, MMP13, MMP14, Agg1 and Agg2 prote-
ases, TIMP1 and TIMP2—their inhibitors—and IL1 and
TNFα cytokines.
A statistical analysis was performed by means of the
Statistica software (Statsoft Inc., Licence No. SN
AXAP911E504325AR-K). The level of statistical signifi-
cance was established at p <0.05. Distribution normality was
verified by the Shapiro-Wilk test. Non-parametric tests (the U
Mann-Whitney’s test and the Kruskal-Wallis one-way analy-
sis of variance) were applied because of considerable devia-
tions from normality. Differences among the subgroups were
validated by the Mann–Whitney’s U test. Correlations were
evaluated by the Spearman’s rank correlation tests.
The study protocol was approved by the Bioethical Com-
mission (Approval No. RNN/125/09/KE).
Clinical outcomes
An intraoperative evaluation of operated joints revealed ACL
lesions in 56 patients. Medial meniscus (MM) lesions were
diagnosed in 65 patients, whereas 11 patients demonstrated
lateral meniscus (LM) damage. MM lesions were also
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observed in 21 and LM in five patients with an injured cruciate
ligament. Joint surface evaluation revealed Grade I, according
to Outerbridge’s grading system, in seven patients, grade II in
32, grade III in 25 and grade IV in four patients. Seventy
patients did not show any hyaline cartilage abnormalities.
Among the patients with affected hyaline cartilage, ACL tear
was identified in 11 patients, out of whom, four also presented
with MM injury. Meniscal lesions were found in 30 patients,
being concomitant with cartilage surface injuries (Fig. 1).
Laboratory tests
While analysing the effects of ACL injuries on the
expression level of studied genes, the lack of any sig-
nificant correlation was observed only in case of TIMP1
in peripheral blood. Regarding all the other genes, the
level of their expression increases with ligament injury
progressions (p <0.05).
In patients withMM lesions, statistically significant chang-
es were found for MMP9, Agg2 and TIMP2 in peripheral
blood and MMP13 in the synovial membrane. We also ob-
served that, while MMP9 and Agg2 expression levels were
growing with MM injuries, the levels of MMP13 (synovial
membrane) and TIMP2 (peripheral blood) were higher in
patients with normal (unaffected) meniscus. LM injuries sig-
nificantly increased MMP13 and MMP14 gene expression
levels in peripheral blood. In addition, we noted higher ex-
pression levels of the MMP8 gene in synovial membranes of
the patients with normal lateral meniscus vs. those with in-
jured LM (p <0.05).
Analysing the effects of articular surface injury, only a
statistically significant increase of TIMP2 expression level
was noted in both studied tissues, while no correlation was
indicated, either for MMP13, MMP14 or TIMP1 in peripheral
blood or for MMP8, MMP14 or TIMP1 in synovial mem-
brane cells. In turn, the other studied genes demonstrated
higher expression levels in the patients with normal hyaline
cartilage.
In a subsequent stage of the study, we compared the effects
of concomitant meniscus and articular cartilage injuries on
gene expression levels in patients with torn ACL. Statistically
significant injuries were observed in only nine enzymes. Re-
garding the synovial membrane, MMP1, MMP2 and MMP13
gene expression levels were lower in the patients with injuries
of both anterior cruciate ligament and meniscus plus articular
surface.Moreover, MMP2 demonstrated its lowest values also
in the patients with torn ACL and injured articular cartilage.
Additional injuries of intra-articular structures bring about
significantly higher expression of the membranous MMP 8
andMMP9 genes. Isolated ACL injuries caused increased IL1
expression levels and significant decreases in TIMP2 expres-
sion levels in synovial membrane, as well as in MMP1 and
MMP2 expression levels in peripheral blood cells. The other
assays revealed statistically insignificant differences only
(Table 1).
In the final stage of the study, we checked whether the
results, obtained for synovial membrane, corresponded with
those for systemic blood cells. Significant correlations were
confirmed among all the studied gene expressions. The stron-
gest correlation was obtained for Agg1 (r =0.89) and for
MMP1 (r =0.88) and MMP2 (r =0.87). The weakest, but
statistically significant, correlation was obtained for MMP8.
The results indicate that, in the course of gene expression
changes in synovial membrane, the same changes occurred











Fig. 1 Distribution of
intraoperatively identified knee
joint lesions (ACL anterior
cruciate ligament, LM lateral
meniscus, MM medial meniscus,
Ch articular cartilage)
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Discussion
It appears from the definition, established in Monterey, that
osteoarthritis includes, among others, destabilisation of bio-
chemical and molecular processes, which may lead to damage
of the joint constituting tissues, resulting in pain disorders and
gradually reduced mobility of the affected joint [20]. One of the
aetiological factors, which may contribute to OA development,
is the history of trauma. Gelbert et al. noted that 13.9 % of
subjects with knee joint trauma in their history had presented
with degenerative changes already before the 65th year of life,
while it had been merely 6 % in the control group. [3] The
Framingham study revealed a five-fold higher risk of osteoar-
thritis occurrence in patients after knee joint injury [4].
Monemdjou described MMP1 and MMP13 as the ‘‘major”
mediators of articular cartilage degradation; additionally,
Tchetvierikov observed increased proMMP1 levels in cases
after articular trauma [10, 12]. In Tajim’s opinion, intra-
articular haematoma may increase MMP2 and MMP9 levels
[11]. This corresponds with our data, obtained in patients with
injured ACL, where almost all gene expression levels were
statistically increased. Zhou et al. also observed increased
MMP2 levels in subjects with injured ACL [21]. Increased
MMP1, IL6, TNFα and TIMP1 levels, observed in case of
torn ACL, were also observed by Taskiran et al. [22] and by
Higuchi et al. [23]. It should be noted that TIMP1 levels,
assayed in the peripheral blood, did not show any statistically
significant differences.
The assay of genes, performed by Foos for nine metallo-
proteinases of the extracellular matrix in ACLs, collected from
cadavers, seems to be a fairly interesting observation. The
author suggests that it may influence reconstruction of this
ligament after trauma [13]. Our results may suggest very
active processes of tissue metabolism in our patients with
injured ACL, simultaneously validating Foos’ observations.
The fact that only TIMP1 levels in peripheral blood were not
increased in the examined patients with torn ACL may be
regarded as additional evidence.
Taking into account the fact that ACL tear is often accom-
panied by injuries of other intra-articular tissues, the influence
of concomitant injuries on expression levels of the studied
genes was also evaluated. Following the conclusions from the
report by Sun et al. [16], changes in meniscus structure result
in changes within the entire knee joint. Ishihara reports in-
creased activities of MMP3 and of Agg1 and Agg2 in menis-
cuses of subjects with OA symptoms [15]. Liao et al. [24]
revealed upregulation of some protein expression in patients
with meniscal lesions. Regarding the study group, similar,
increased Agg2 levels were obtained only in the patients with
injured MM. It should also be noted that the patients with
normal (intact) meniscuses in our study demonstrated higher
MMP13 expression levels vs. the patients with injured MM. It
should be emphasised that MMP13 is regarded to be one of
the metalloproteinases most important for OA development
[10, 21, 25]. Also evaluated was the expression of genes of the
inflammatory process cytokines. Regarding the patients with
torn ACL, increased IL1 and TNFα expression levels were
obtained in all the studied tissues. Similarly, increased levels
of these enzymes in subjects after trauma have been described
by Rutgers, who also emphasised the role of IL6, IL8 and
IL10 [26]. We would like to draw attention to the fact that, in
cases of injured meniscus and articular cartilage, no signifi-
cant differences were observed, which corresponds to the
report of Manicourt et al. [14], who found that TNFα levels
do not correlate with cartilage degradation markers. In con-
trast to that view, Ji et al. [27] report that allele ‘A’ of TNFα
may increase the risk of OA. Having analysed the effects of
articular cartilage injury, we observed higher expression levels
Table 1 Expression changes of the studied genes vs. the type of knee joint injury (p <0.05; ↑ increase in affected subjects, ↓ increase in normal subjects,
↔ no statistical significance)
Test medium ACL MM LM Cartilage
Synovial
membrane
All ↑ MMP13↑ the other↔ MMP8↓ the other↔ TIMP2↑MMP8↔MMP14↔ TIMP1↔
the other ↓






ACL anterior cruciate ligament, LM lateral meniscus, MM medial meniscus
Table 2 Correlations between studied gene expression levels in the
synovial membrane and blood (p <0.05)
Comparison Correlation, r p
Synovium-MMP1 - Blood-MMP1 0.88 0.0000
Synovium-MMP2 - Blood-MMP2 0.87 0.0000
Synovium-MMP8 - Blood-MMP8 0.45 0.0000
Synovium-MMP9 - Blood-MMP9 0.60 0.0000
Synovium-MMP13 - Blood-MMP13 0.57 0.0000
Synovium-MMP14 - Blood-MMP14 0.73 0.0000
Synovium-Agg1 - Blood-Agg1 0.89 0.0000
Synovium-Agg2 - Blood-Agg2 0.84 0.0000
Synovium-IL1 - Blood-IL1 0.82 0.0000
Synovium-TNF - Blood-TNF 0.77 0.0000
Synovium-TIMP1 - Blood-TIMP1 0.58 0.0000
Synovium-TIMP2 - Blood-TIMP2 0,61 0.0000
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for the majority of protease genes in normal subjects, i.e., with
intact articular cartilage vs. those with injured articular sur-
faces (Fig. 1).
In his study, Naito found that MMP3 andMMP9 levels did
not correlate with the radiological stage of the disease. How-
ever, most of the authors report increased levels of proteolytic
enzymes in subjects with osteoarthritis [10, 28, 29].
Similarly, El-Arman et al. [30] obtained positive correlations
between enzyme levels in peripheral blood and in the knee
joint. Also Poole et al., using 846 epitope, achieved a positive
correlation between the levels of articular cartilage aggrecans in
plasma and articular fluid [31]. Similarly, Fraser et al. described
a correlation of local OA markers with systemic markers [32].
We would, however, like to emphasise the fact that the majority
of literature reports describe enzyme level assays in the articular
fluid, whereas we assayed expression levels of the genes cor-
responding to those proteins. According to these facts we
suggest that further research with longer follow up should be
conducted to establish whether genes expression elevations
could be prognostic for OA in future.
Conclusions
1. Gene expression levels in hyaline cartilage proteases of
the synovial membrane correlate with peripheral blood
cells.
2. Cruciate ligament injuries increase gene expression levels
in hyaline cartilage proteases.
3. Possible effects of damage of other articular structures
remain unclear, demanding further studies.
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